INMB
Price
$2.71
Change
-$0.07 (-2.52%)
Updated
Jul 25 closing price
Capitalization
73.82M
3 days until earnings call
PROK
Price
$3.29
Change
+$0.03 (+0.92%)
Updated
Jul 25 closing price
Capitalization
438.95M
11 days until earnings call
Interact to see
Advertisement

INMB vs PROK

Header iconINMB vs PROK Comparison
Open Charts INMB vs PROKBanner chart's image
INmune Bio
Price$2.71
Change-$0.07 (-2.52%)
Volume$1.34M
Capitalization73.82M
ProKidney
Price$3.29
Change+$0.03 (+0.92%)
Volume$2.79M
Capitalization438.95M
INMB vs PROK Comparison Chart in %
Loading...
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INMB vs. PROK commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMB is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (INMB: $2.71 vs. PROK: $3.29)
Brand notoriety: INMB and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INMB: 36% vs. PROK: 16%
Market capitalization -- INMB: $73.82M vs. PROK: $438.95M
INMB [@Biotechnology] is valued at $73.82M. PROK’s [@Biotechnology] market capitalization is $438.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INMB’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • INMB’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, PROK is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INMB’s TA Score shows that 4 TA indicator(s) are bullish while PROK’s TA Score has 5 bullish TA indicator(s).

  • INMB’s TA Score: 4 bullish, 6 bearish.
  • PROK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PROK is a better buy in the short-term than INMB.

Price Growth

INMB (@Biotechnology) experienced а +12.19% price change this week, while PROK (@Biotechnology) price change was +4.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

INMB is expected to report earnings on Jul 30, 2025.

PROK is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($439M) has a higher market cap than INMB($73.8M). PROK YTD gains are higher at: 94.675 vs. INMB (-41.863). INMB has higher annual earnings (EBITDA): -41.52M vs. PROK (-160.12M). PROK has more cash in the bank: 328M vs. INMB (19.3M). INMB has less debt than PROK: INMB (347K) vs PROK (3.37M). PROK has higher revenues than INMB: PROK (306K) vs INMB (50K).
INMBPROKINMB / PROK
Capitalization73.8M439M17%
EBITDA-41.52M-160.12M26%
Gain YTD-41.86394.675-44%
P/E RatioN/AN/A-
Revenue50K306K16%
Total Cash19.3M328M6%
Total Debt347K3.37M10%
FUNDAMENTALS RATINGS
INMB: Fundamental Ratings
INMB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INMBPROK
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
67%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 3 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
65%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGCIX132.630.58
+0.44%
Gabelli Growth I
SSAQX78.740.27
+0.34%
State Street US Core Equity Fund
FXRVF0.42N/A
N/A
Fox Riv Res Corp
FAOCX35.71-0.07
-0.20%
Fidelity Advisor Overseas C
YGRAF0.76-0.02
-2.19%
Yangarra Resources Ltd.

INMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMB has been loosely correlated with UNBX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then UNBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMB
1D Price
Change %
INMB100%
-2.34%
UNBX - INMB
51%
Loosely correlated
-2.78%
GBIO - INMB
36%
Loosely correlated
+9.76%
PROK - INMB
36%
Loosely correlated
+0.92%
ABCL - INMB
35%
Loosely correlated
+1.79%
OVID - INMB
35%
Loosely correlated
-10.75%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with CYCC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+0.92%
CYCC - PROK
57%
Loosely correlated
-6.47%
RLYB - PROK
46%
Loosely correlated
-4.83%
LGVN - PROK
42%
Loosely correlated
-1.18%
NRIX - PROK
39%
Loosely correlated
-0.09%
APGE - PROK
38%
Loosely correlated
-1.97%
More